title: Galactomannan in piperacillin-tazobactam: how much and to what extent?
authors.forename: Marco
authors.initials: M
authors.lastname: Machetti
authors.forename: Elisa
authors.initials: E
authors.lastname: Furfaro
authors.forename: Claudio
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D000900:Anti-Bacterial Agents / Q000032:analysis*; D001228:Aspergillosis / Q000175:diagnosis / Q000378:metabolism / Q000382:microbiology; D004340:Drug Contamination; D005690:Galactose / Q000031:analogs & derivatives; D006801:Humans; D008351:Mannans / Q000032:analysis*; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000032:analysis; D010878:Piperacillin / Q000032:analysis; D000077725:Piperacillin, Tazobactam Drug Combination
chemical_list: D000900:Anti-Bacterial Agents; D008351:Mannans; C012990:galactomannan; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin; D005690:Galactose